Skip to content

Reducing Hemodialysis Catheter Use in Prevalent Hemodialysis Patients

Reducing Hemodialysis Catheter Use in in a Prevalent Hemodialysis Population; A Pilot Randomized Control Trial

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01053117
Enrollment
3
Registered
2010-01-21
Start date
2009-02-28
Completion date
2012-08-31
Last updated
2014-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Keywords

central venous catheter, arteriovenous fistula, hemodialysis, vascular access, dialysis

Brief summary

To determine if a protocolized approach to converting hemodialysis central venous catheters (CVC) to arteriovenous fistulae will improve rates of functioning AVF and decrease CVC use.

Detailed description

In order to receive dialysis, patients require repeated access to their bloodstream. This access can be either via a central venous catheter (CVC) or a surgically created arteriovenous fistula (AVF) or graft (AVG). This is a pilot randomized control trial of prevalent hemodialysis patients with a central venous catheter (CVC), to determine if a systematic approach using an algorithm protocol to convert the CVC to an AVF (arteriovenous fistula) will improve rates of functioning AVF and decrease CVC use. The algorithm (intervention group) will be compared to current practice (control group), a non-standardized approach at the discretion of the caring nephrologist and/or surgeon.

Interventions

OTHERProtocolized approach to convert dialysis catheter to fistula

This group will be assigned an algorithm protocol in efforts to convert the central venous catheter to an arteriovenous fistula. A case manager will be assigned to follow these patients and implement the protocol

Sponsors

Health Sciences Centre Foundation, Manitoba
CollaboratorOTHER
Dr. Lisa Miller
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years of age * Dialyzing with a CVC * Receiving hemodialysis three times weekly for \> 3 months

Exclusion criteria

* Awaiting peritoneal dialysis catheter insertion * Scheduled living donor transplant * Transient patients from out of province * Expected transfer to satellite dialysis unit within 6 months * Surgical plan for AVF (i.e. scheduled date) * Documented lack of suitable vasculature for AVF * Refusing AVF

Design outcomes

Primary

MeasureTime frame
The proportion of patients using a CVC in a prevalent hemodialysis population after the implementation of an algorithm protocol to convert the CVC to an AVF compared with patients who received current standard care.9 months

Secondary

MeasureTime frame
The proportion of patients with a functioning AVF after the implementation of an algorithm protocol to convert the CVC to an AVF compared with patients who received current standard care.9 months
Proportion of patients with a maturing AVF9 months
Primary fistula failure rate9 months
Incidence of AVF salvage procedures, including balloon angioplasty and accessory vein ligation, within 9 months of AVF creation9 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026